Allopregnanolone levels decrease after gonadotropin-releasing hormone analog stimulation test in girls with central precocious puberty

被引:0
|
作者
Predieri, B. [1 ]
Luisi, S. [2 ]
Casarosa, E. [3 ]
Farinelli, E. [4 ]
Antoniazzi, F. [5 ]
Wasniewska, M. [6 ]
Bernasconi, S. [7 ]
Petraglia, F. [2 ]
Iughetti, L. [1 ]
机构
[1] Univ Modena & Reggio Emilia, Dept Pediat, I-41100 Modena, Italy
[2] Univ Siena, Dept Obstet & Gynecol, I-53100 Siena, Italy
[3] Univ Pisa, Dept Reprod Med & Child Dev, Pisa, Italy
[4] Univ Perugia, Dept Pediat, I-06100 Perugia, Italy
[5] Univ Verona, Dept Pediat, I-37100 Verona, Italy
[6] Univ Messina, Dept Pediat, Messina, Italy
[7] Univ Parma, Dept Pediat, I-43100 Parma, Italy
关键词
Neurosteroids; allopregnanolone; GnRH analog; central precocious puberty; LUTEINIZING-HORMONE; SERUM; OVARIAN; NEUROSTEROIDS; SECRETION; ESTRADIOL; AGONIST; BRAIN; MECHANISMS; DIAGNOSIS;
D O I
10.1007/BF03346693
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Allopregnanolone, a neuroactive steroid mainly secreted by adrenals and gonads, is a hormone that seems to play a role in precocious puberty, as demonstrated by its high baseline levels found in girls with central precocious puberty (CPP). Allopregnanolone concentrations significantly increase after GnRH and ACTH stimulation test suggesting both its ovarian and adrenal production. Aim: Aim of this study was to evaluate allopregnanolone concentrations after GnRH and GnRH agonist analog stimulation test in girls with CPP to better establish its secretion source. Subjects and methods: Gonadotropins and steroid hormones were evaluated in different days after GnRH and triptorelin stimulation test in 15 CPP girls. Results: After GnRH stimulation, LH, FSH, and allopregnanolone concentrations significantly increased (p < 0.05). After triptorelin administration LH, FSH, estradiol and DHEAS levels significantly increased (p < 0.05), while allopregnanolone concentrations significantly decreased (1.08 +/- 0.24 vs 0.87 +/- 0.28 nmol/l; p=0.003). Conclusions: The different response of allopregnanolone to GnRH and GnRH agonist analog might reflect the agonist and antagonist action exerted by these secretagogues. Our data suggest the prevalent gonadal allopregnanolone production in CPP subjects and the usefulness of its measurement in the diagnosis of CPP. (J. Endocrinol. Invest. 34: 38-44, 2011) (C)2011, Editrice Kurtis
引用
收藏
页码:38 / 44
页数:7
相关论文
共 50 条
  • [31] THE INFLUENCE OF GONADOTROPIN-RELEASING HORMONE AGONISTS ON BODY MASS INDEX IN GIRLS WITH CENTRAL PRECOCIOUS PUBERTY
    Lee, Jieun
    Kim, Jae Hyun
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 179 - 180
  • [32] Idiopathic scoliosis in girls with central precocious puberty: Incidence and effect of gonadotropin-releasing hormone agonists
    Chung, Lindsey Yoojin
    Nam, Hyo-Kyoung
    Rhie, Young-Jun
    Huh, Rimm
    Lee, Kee-Hyoung
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 262 - 262
  • [33] Evaluation of Electrocardiographic Changes in Girls Receiving Gonadotropin-Releasing Hormone Analogs for Central Precocious Puberty
    Er, Eren
    Ata, Aysun
    Orgun, Ali
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 386 - 387
  • [34] A single-sample, subcutaneous gonadotropin-releasing hormone test for central precocious puberty
    Eckert, KL
    Wilson, DM
    Bachrach, LK
    Anhalt, H
    Habiby, RL
    Olney, RC
    Hintz, RL
    Neely, EK
    PEDIATRICS, 1996, 97 (04) : 517 - 519
  • [35] Review of Outcomes After Cessation of Gonadotropin-releasing Hormone Agonist Treatment of Girls with Precocious Puberty
    Thornton, Paul
    Silverman, Lawrence A.
    Geffner, Mitchell E.
    Neely, E. Kirk
    Gould, Errol
    Danoff, Theodore M.
    PEDIATRIC ENDOCRINOLOGY REVIEWS PER, 2014, 11 (03) : 306 - 317
  • [36] Treatment of Central Precocious Puberty Using Gonadotropin-releasing Hormone Agonists
    Cafasso, Mandi
    Elder, Deborah A.
    Blum, Samantha
    Weis, Tammy
    Hornung, Lindsey
    Khoury, Jane C.
    Stenger, Peggy J.
    Rose, Susan R.
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2015, 11 (07): : 686 - 694
  • [37] Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls
    Shi, Yuzhen
    Ma, Ziyi
    Yang, Xi
    Ying, Yanqin
    Luo, Xiaoping
    Hou, Ling
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [38] Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty
    Weise, M
    Flor, A
    Barnes, KM
    Cutler, GB
    Baron, J
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01): : 103 - 107
  • [39] Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty
    Lee, Hae Sang
    Yoon, Jong Seo
    Park, Kyu Jung
    Hwang, Jin Soon
    PLOS ONE, 2018, 13 (08):
  • [40] Time to Menarche after Completing Gonadotropin-Releasing Hormone Agonist in Girls with Central Precocious or Early-Onset Puberty
    Kim, Shin-Hee
    Jung, In Ah
    Choi, Won Kyoung
    Cho, Kyoung Soon
    Park, So Hyun
    Jung, Min Ho
    Suh, Byung Kyu
    ENDOCRINE REVIEWS, 2014, 35 (03)